how was glp-1 discovered The transformative breakthroughs in research recognized by the 2024 Lasker~DeBakey award | Current Medicine How do GLP-1 agonists affect

Scientists have long recognised the potential benefits of transdermal drug delivery, including improved patient compliance, steady drug release, and avoidance of gastrointestinal degradation and first-pass metabolism

* Gradually increase the amount of fibre intake once the symptoms improve

TABLE 2 outlines a practical approach based on the Three Es method that pharmacists can use to systematically educate patients and manage GI AEs associated with GLP-1 RA therapy

It also delays gastric emptying, inhibits glucagon release from pancreatic alpha cells, causes the proliferation of beta cells, and decreases their apoptosis

These arent just theoretical conceptstheyre on the horizon